Document is current
Any future updates will be listed below
-
Authors
Chen, Junren https://orcid.org/0000-0003-3691-4931
Gale, Robert Peter https://orcid.org/0000-0002-9156-1676
- License Information
-
More Information
Article History
Received: 18 November 2025
Revised: 19 December 2025
Accepted: 20 January 2026
First Online: 29 January 2026
Competing interests
: RPG is a consultant to Antengene Biotech LLC and Shenzhen TargetRx; Medical Director of FFF Enterprises Inc.; has served as a speaker for Janssen Pharmaceuticals, BeOne Medicines (formerly BeiGene), and Jiangsu Hengrui Pharmaceuticals; and has served on the Boards of Directors of the Russian Imperial Foundation for Cancer Research and StemRad.
